drugset / Trial / NCT00369473
Long-Term Assessment of Safety and Physical Function With AMG 108 in RA
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to assess long-term safety of SC AMG 108 in the treatment of RA
Timeline
- Start
- 2006-09
- Primary completion
- 2008-06
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AMG 108 | Monoclonal antibody | 125 mg | Subcutaneous |
| Subject | AMG 108 | Monoclonal antibody | 250 mg | Subcutaneous |